The effects of antimuscarinics on health-related quality of life in overactive bladder: a systematic review and meta-analysis.
about
Which anticholinergic drug for overactive bladder symptoms in adultsAdverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approachPatient-reported outcomes with botulinum neurotoxin type A.CUA guideline on adult overactive bladderAdditional low-dose antimuscarinics can improve overactive bladder symptoms in patients with suboptimal response to beta 3 agonist monotherapy.Medical management of overactive bladderPercutaneous tibial nerve stimulation: a clinically and cost effective addition to the overactive bladder algorithm of care.Potential benefits of diagnosis and treatment on health outcomes among elderly people with symptoms of overactive bladder.Overactive bladder - 18 years - Part IILower urinary tract symptoms in women-a common but neglected problem.Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin.Antimuscarinic Agent Treatment Affecting Patient-Reported Outcomes in Overactive Bladder Syndrome With Depressive Symptoms.Patient-reported outcomes and different approaches to urinary parameters in overactive bladder: what should we measure?Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability.The psychological impact of overactive bladder: A systematic review.Solifenacin treatment in men with overactive bladder: effects on symptoms and patient-reported outcomes.Tolerability and persistence in a large, prospective case series of women prescribed mirabegron.Correlations among Lower Urinary Tract Symptoms, Bother, and Quality of Life in Patients with Benign Prostatic Hyperplasia and Associated Fluctuations with Tamsulosin Administration.Validity and reliability of patient selected goals as an outcome measure in overactive bladder.Solifenacin for overactive bladder: patient-reported outcomes from a large placebo-controlled trial.Differential effects of selective and non-selective muscarinic antagonists on gastrointestinal transit and bowel function in healthy women.Relationships between symptoms, symptom bother, and health-related quality of life in patients with overactive bladder taking solifenacin or placebo in the VIBRANT study.Third-line treatment for overactive bladder: should mirabegron be tried before intravesical botulinum toxin A therapy?Effects of propiverine hydrochloride, an anticholinergic agent, on urethral continence mechanisms and plasma catecholamine concentration in rats.Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study.Correlation between improvements in Overactive Bladder Symptom Score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug.Comparison of intravaginal electrical stimulation and trospium hydrochloride in women with overactive bladder syndrome: a randomized controlled study.Comparison of different treatment protocols in the treatment of idiopathic detrusor overactivity: a randomized controlled trial.
P2860
Q24203880-8207A733-53FC-4722-9910-3D85BEE2E9CEQ28742444-A0FD528F-7587-4CE8-AB09-843F1AAE3B5EQ33299851-E3EDA288-0EE7-400C-9ED8-6278B0FCF84EQ33665026-AE4B19AC-C4FD-456C-932D-68FF3801A6A1Q33863110-D124B438-8B4E-4C21-B348-9A704EDF995EQ34124065-B4D2A699-F7A4-4FD6-BDEE-36D8784E7192Q36223634-7BC7A656-F8A3-4AF1-88E2-E036DFC6158AQ36537032-8D47316F-AAD9-4B57-927A-697FA201B953Q36912766-A2900BD6-BBB8-4391-B9C9-31EA323FCB47Q37202902-EFAFEA3A-3455-47EF-AE0A-E842F1386286Q37405499-9ED8FFDE-669E-415E-B9E8-7046C090413CQ37553954-BB1FC1B7-CA13-43BF-8396-51DCCE2DB73DQ37947438-4D30D59E-A98A-40E7-B852-17AFD3188F84Q38152756-204BE029-F801-4D10-8302-2080A4CBBBF3Q38193008-365E2AF7-1933-43F9-8AEC-7261716B525FQ39294461-593F71A4-49CE-4CAB-8FBE-C16DD07BE9B0Q40068468-86D68FE4-045E-411C-972B-1CE172F22434Q40202819-412C2133-5200-4EA5-8A7E-63717499375FQ42688194-9A4B126D-8C06-4111-B475-F15E75DF4845Q43263705-53B8C64F-A457-4ADA-B402-81A6BE453BBDQ45997528-A20A9DEB-99A1-4C1C-9DA4-E97CC1969DD9Q46063282-4DD1D71A-939B-44F9-84FA-91EA2988AA76Q46517434-BB5FB9A6-3A9B-481B-ACBD-C93404CEFB21Q46862655-0C472F46-DB03-4667-8254-24A2482BDDFBQ47655067-8B20D53B-16D0-4C4C-BF59-8E178E8BEC13Q48673293-50297888-2B43-48F5-8625-683D78FF9865Q48868791-D5BBDBEB-1E57-4F61-90E9-189E8B50BD36Q51537878-3293A7E2-86C1-4243-9F91-4C6ED2581106
P2860
The effects of antimuscarinics on health-related quality of life in overactive bladder: a systematic review and meta-analysis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The effects of antimuscarinics ...... atic review and meta-analysis.
@ast
The effects of antimuscarinics ...... atic review and meta-analysis.
@en
type
label
The effects of antimuscarinics ...... atic review and meta-analysis.
@ast
The effects of antimuscarinics ...... atic review and meta-analysis.
@en
prefLabel
The effects of antimuscarinics ...... atic review and meta-analysis.
@ast
The effects of antimuscarinics ...... atic review and meta-analysis.
@en
P2093
P1433
P1476
The effects of antimuscarinics ...... atic review and meta-analysis.
@en
P2093
Julie Ann Dooley
Vik Khullar
Zahava Gabriel
P356
10.1016/J.UROLOGY.2006.05.043
P407
P433
P577
2006-08-01T00:00:00Z